StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) stock

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$332.16−3.36 (-1.00%)

Close on Nov 17, 2026Market cap $15.86BP/E –Yield –

Charles River Laboratories International profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Charles River Laboratories International's profit margin for the twelve months ending Jun 27, 2026 was -6.0%. For fiscal 2025 it was -3.6%, against 0.5% the year before. The highest annual figure on record is 12.5% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 27, 2025-3.6%−4.1
FY2024Dec 28, 20240.5%−10.9
FY2023Dec 30, 202311.5%−0.7
FY2022Dec 31, 202212.2%+1.2
FY2021Dec 25, 202111.0%−1.4
FY2020Dec 26, 202012.5%+2.8
FY2019Dec 28, 20199.6%−0.4
FY2018Dec 29, 201810.0%+3.3
FY2017Dec 30, 20176.6%−2.6
FY2016Dec 31, 20169.2%−1.7
FY2015Dec 26, 201511.0%+1.2
FY2014Dec 27, 20149.8%+0.9
FY2013Dec 28, 20138.8%+38.5
FY2010Dec 25, 2010-29.7%−39.5
FY2009Dec 26, 20099.8%+50.3
FY2008Dec 27, 2008-40.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 27, 2026-0.1%−5.2
Q1 FY2026Mar 28, 2026-1.5%−4.1
Q4 FY2025Dec 27, 2025-27.8%−6.4
Q3 FY2025Sep 27, 20255.4%−1.5
Q2 FY2025Jun 28, 20255.1%−4.1
Q1 FY2025Mar 29, 20252.6%−4.6
Q4 FY2024Dec 28, 2024-21.4%−39.9
Q3 FY2024Sep 28, 20246.9%−1.6
Q2 FY2024Jun 29, 20249.2%+0.0
Q1 FY2024Mar 30, 20247.2%−2.8
Q4 FY2023Dec 30, 202318.5%+1.4
Q3 FY2023Sep 30, 20238.5%−1.2
Q2 FY2023Jul 1, 20239.2%−2.1
Q1 FY2023Apr 1, 202310.0%−0.2
Q4 FY2022Dec 31, 202217.0%+1.8
Q3 FY2022Sep 24, 20229.8%−1.8
Q2 FY2022Jun 25, 202211.2%+1.6
Q1 FY2022Mar 26, 202210.2%+2.7
Q4 FY2021Dec 25, 202115.2%−2.9
Q3 FY2021Sep 25, 202111.5%−2.3
Q2 FY2021Jun 26, 20219.7%−0.2
Q1 FY2021Mar 27, 20217.5%+0.3
Q4 FY2020Dec 26, 202018.1%+6.5
Q3 FY2020Sep 26, 202013.8%+2.9
Q2 FY2020Jun 27, 20209.9%+3.2
Q1 FY2020Mar 28, 20207.2%−1.9
Q4 FY2019Dec 28, 201911.6%+1.7
Q3 FY2019Sep 28, 201910.9%+0.6
Q2 FY2019Jun 29, 20196.6%−2.5
Q1 FY2019Mar 30, 20199.1%−1.5
Q4 FY2018Dec 29, 20189.9%+16.2
Q3 FY2018Sep 29, 201810.3%−1.0
Q2 FY2018Jun 30, 20189.2%−2.3
Q1 FY2018Mar 31, 201810.7%+0.2
Q4 FY2017Dec 30, 2017-6.2%−15.8
Q3 FY2017Sep 30, 201711.3%+2.4
Q2 FY2017Jul 1, 201711.5%–
Q1 FY2017Apr 1, 201710.5%–
Q4 FY2016Dec 31, 20169.6%–
Q3 FY2016Sep 24, 20168.9%–

More Charles River Laboratories International figures

See a number that looks wrong?